<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>PCMA SmartBrief</title><description>Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. &amp;nbsp;Click&amp;nbsp; &lt;a href='http://www.smartbrief.com/pcma/index.jsp?sb_code=rss'&gt;here&lt;/a&gt; to subscribe.</description><link>http://www.smartbrief.com/news/pcma?sb_code=rss</link><image><url>http://www.smartbrief.com/images/homepage/hed-smartbrief.gif</url><title>PCMA SmartBrief</title><link>http://www.smartbrief.com/news/pcma?sb_code=rss</link></image><language>en-us</language><lastBuildDate>24 May 2013 10:42:48 CDT</lastBuildDate><item><title>Preventing seniors from using preferred networks will create "political backlash"</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D56EB09D4-552F-4A76-9EA1-16005C491535%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D56EB09D4-552F-4A76-9EA1-16005C491535%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">With more than 40% of seniors in Medicare Part D enrolled in a plan with a preferred network and a new survey showing that an&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D56EB09D4-552F-4A76-9EA1-16005C491535%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Featured Story</category></item><item><title>Survey: 85% of Part D seniors in preferred pharmacy plans are satisfied with costs, pharmacy choices</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D23C01792-A8AC-4939-80F9-F8C5693CC349%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D23C01792-A8AC-4939-80F9-F8C5693CC349%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D23C01792-A8AC-4939-80F9-F8C5693CC349%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Featured Story</category></item><item><title>Hart Research Associates: A survey of seniors about their Medicare Part D preferred pharmacy network plan</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF87BDF84-DC93-49FD-932F-D5B122EC8496%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF87BDF84-DC93-49FD-932F-D5B122EC8496%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF87BDF84-DC93-49FD-932F-D5B122EC8496%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Featured Story</category></item><item><title>How pharmacy networks could save Medicare, Medicaid, and commercial payers $115 billion</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF55B4A87-34C3-4AAB-9A07-D82183BA25A5%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF55B4A87-34C3-4AAB-9A07-D82183BA25A5%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF55B4A87-34C3-4AAB-9A07-D82183BA25A5%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Featured Story</category></item><item><title>Report: Upgrading Medicaid drug benefits could save federal, state governments $74.4 billion</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DFE5A50D0-4570-4572-92E0-059FBBB18580%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DFE5A50D0-4570-4572-92E0-059FBBB18580%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DFE5A50D0-4570-4572-92E0-059FBBB18580%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Featured Story</category></item><item><title>FDA would also regulate nonsterile meds under new compounding bill</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DA43AF3A9-749D-46FA-8F86-A3E6DA5E500E%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DA43AF3A9-749D-46FA-8F86-A3E6DA5E500E%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Rep. &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DA43AF3A9-749D-46FA-8F86-A3E6DA5E500E%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Legislative &amp; Regulatory News</category></item><item><title>Study warns it's only a matter of time before another compounding disaster</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D2AB7FD3C-D687-40AC-8AF9-4C126BB05D2C%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D2AB7FD3C-D687-40AC-8AF9-4C126BB05D2C%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D2AB7FD3C-D687-40AC-8AF9-4C126BB05D2C%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Legislative &amp; Regulatory News</category></item><item><title>Calif. exchange takes shape with 13 insurers, rate estimates</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF7BB4D73-F5CA-47B6-AB9D-44EB2C0A79AA%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF7BB4D73-F5CA-47B6-AB9D-44EB2C0A79AA%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Preliminary rate information suggests individuals who buy health coverage through the Covered California exchange will pay ab&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DF7BB4D73-F5CA-47B6-AB9D-44EB2C0A79AA%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Legislative &amp; Regulatory News</category></item><item><title>J&amp;J to seek approval of more than 10 new drugs in 4 years</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D509E5529-AEE2-41DD-B824-84CE99A1EE99%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D509E5529-AEE2-41DD-B824-84CE99A1EE99%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Johnson & Johnson said its pharmaceuticals group intends to file regulatory applications for more than 10 new drugs and seek &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D509E5529-AEE2-41DD-B824-84CE99A1EE99%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Drug Industry Spotlight</category></item><item><title>Glenmark pulls 3 therapies from U.S. over "odd smell"</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D3DB3D880-3503-432B-A283-B93EF1FC9E0F%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D3DB3D880-3503-432B-A283-B93EF1FC9E0F%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Glenmark Generics has recalled multiple lots of gabapentin, pravastatin sodium and topiramate in the U.S. &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D3DB3D880-3503-432B-A283-B93EF1FC9E0F%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Drug Industry Spotlight</category></item><item><title>Sandoz's generic hypertension therapy gets FDA OK</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D72976F33-7390-460D-880C-BC5A25A84F3A%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D72976F33-7390-460D-880C-BC5A25A84F3A%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D72976F33-7390-460D-880C-BC5A25A84F3A%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Drug Industry Spotlight</category></item><item><title>SmartBrief will not publish Monday</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DBC59AF35-1E73-4AFB-A484-6DBED779158E%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DBC59AF35-1E73-4AFB-A484-6DBED779158E%26brief%3Dpcma%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">In observance of Memorial Day in the U.S., SmartBrief will not publish Monday. Publication will resume Tuesday.&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3DBC59AF35-1E73-4AFB-A484-6DBED779158E%26brief%3DPCMA%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>Editor's Note</category></item><item><title>Only through curiosity can we discover opportunities, and only by gambling can we take advantage of them.</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D55468E0B-1FC5-404C-88C7-80D763D6E490%26brief%3Dpcma%26sb_code%3Drss%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D55468E0B-1FC5-404C-88C7-80D763D6E490%26brief%3Dpcma%26sb_code%3Drss%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Clarence Birdseye,American inventor, entrepreneur and naturalist&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D50BB837D-7473-4B39-B39A-F58C5A978A63%26copyid%3D55468E0B-1FC5-404C-88C7-80D763D6E490%26brief%3DPCMA%26sb_code%3Drss%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>24 May 2013 10:42:48 CDT</pubDate><category>SmartQuote</category></item></channel></rss>